Latest S-1 registration statements
NASDAQ
S-1MEF: Galaxy Digital Amends S-1 Filing to Boost Class A Common Stock Offering by 2.99 Million Shares
Galaxy Digital Inc. has filed an S-1MEF registration statement to increase its Class A common stock offering by 2,990,000 shares, including an underwriters' option, at a proposed maximum price of $19.00 per share.
NASDAQ
Omada Health, Inc. has filed an S-1/A registration statement for its initial public offering of 7,500,000 shares of common stock, with an anticipated price range of $18.00 to $20.00 per share, aiming to raise approximately $133.2 million for general corporate purposes and potential acquisitions.
OTC.Pink
Idaho Copper Corporation has filed an amended registration statement for the resale of over 94 million shares by selling stockholders, highlighting its continued exploration and development efforts for the CuMo project amidst substantial financial losses and a critical need for future financing.
OSR Holdings, a global healthcare holding company, reported a significant increase in net loss and a decrease in net sales for Q1 2025, while securing new dilutive financing agreements to address liquidity challenges following a cancelled $20 million PIPE transaction.
OTC.Pink
Dror Ortho-Design, Inc., a development-stage company with no current revenues, has filed an S-1 registration statement to offer common stock and warrants, seeking to raise capital for its proprietary AI-based ZSmile orthodontic platform while facing substantial doubt about its ability to continue as a going concern.
NASDAQ
GLIBA
Gci Liberty, INCLiberty Broadband is spinning off its subsidiary GCI Liberty, a telecommunications company operating primarily in Alaska, as a prerequisite to its merger with Charter Communications.
NASDAQ
Galaxy Digital Inc. reported a significant net loss in the first quarter of 2025, driven by digital asset price declines, while actively progressing its strategic expansion into high-performance computing (HPC) data centers with key client commitments.
NASDAQ
Galaxy Digital Inc. is undertaking a public offering of Class A common stock to fund the expansion of its artificial intelligence and high-performance computing infrastructure, while navigating a volatile digital asset market and ongoing regulatory developments.
NASDAQ
Medicus Pharma Ltd., a clinical-stage biotech company, has filed an S-1 registration statement for a public offering of up to 1,375,000 units, aiming to raise approximately $10 million to fund its Phase 2 clinical trials for basal cell carcinoma and support general corporate purposes, despite ongoing operating losses and a 'going concern' warning from its auditor.
NYSE
Bitmine Immersion Technologies, a blockchain technology company specializing in bitcoin mining and related services, has filed an S-1/A registration statement for a public offering of 1,875,000 common shares to fund bitcoin acquisitions and expand its mining infrastructure, despite a history of significant net losses.
General Enterprise Ventures, Inc. (GEVI), an environmentally sustainable flame retardant company, has filed an S-1/A registration statement for a public offering of 3,500,000 common shares and intends to list on NYSE American, despite reporting substantial net losses and a going concern qualification from its auditors.
NASDAQ
Twelve Seas Investment Company III, a blank check company, filed an amended registration statement for its $150 million initial public offering, outlining its strategy to acquire non-U.S. companies while disclosing significant dilution risks for public shareholders and potential conflicts of interest involving its management team.
NASDAQ
Medicus Pharma Ltd., a clinical-stage biotech company, has filed an S-1 registration statement to allow for the resale of up to 3.71 million common shares by a selling shareholder, while also disclosing significant operating losses, a going concern warning, and updates on its lead skin cancer drug candidate and a new acquisition.
NASDAQ
S-1: Palisade Bio Launches Public Offering to Fund IBD Drug Development After Positive Phase 1 Results
Palisade Bio, a clinical-stage biopharmaceutical company, announced a public offering of common stock and pre-funded warrants to raise approximately $8.9 million, following positive Phase 1 clinical trial results for its lead IBD candidate, PALI-2108.
NYSE
Circle Internet Group, Inc., the issuer of USDC, has filed an amended S-1 registration statement for its initial public offering, revealing significant revenue growth, expanding global partnerships, and continued innovation in the stablecoin and blockchain sectors.
NASDAQ
Iron Horse Acquisitions Corp. II, a blank check company, filed an amended S-1 registration statement for its initial public offering of 20,000,000 units at $10.00 per unit, aiming to raise $200 million for a business combination primarily within the media and entertainment industry.
NASDAQ
BEST SPAC I Acquisition Corp., a British Virgin Islands blank check company, filed an amended S-1 registration statement for its $55 million initial public offering, aiming to acquire a consumer goods business with an enterprise value between $100 million and $600 million, while disclosing significant risks related to its blank check nature and ties to China.
NASDAQ
Jefferson Capital, Inc., a leading purchaser and manager of charged-off and insolvency consumer accounts, has filed an S-1/A registration statement for its initial public offering, highlighting robust financial performance, strategic acquisitions, and ambitious growth plans across its global operations.
NASDAQ
Slide Insurance Holdings, Inc. has filed for an initial public offering, aiming to leverage its technology-driven platform and expertise in underserved coastal specialty insurance markets.
NASDAQ
Caris Life Sciences, a leading AI TechBio company specializing in precision oncology, has filed for an initial public offering to raise capital for continued innovation and market expansion of its comprehensive molecular profiling solutions, despite significant and ongoing net losses.
NASDAQ
Helius Medical Technologies, a neurotechnology company, has filed an S-1 registration statement for a public offering of common stock and warrants, seeking to raise approximately $13.6 million to address immediate financial needs and Nasdaq listing compliance, while facing substantial dilution for new investors.
NASDAQ
Blue Water Acquisition Corp. III, a newly formed blank check company, filed an amended S-1 registration statement for its initial public offering of 20 million units at $10.00 each, aiming to acquire high-potential businesses in the biotechnology, healthcare, and technology sectors within 24 months.
AMEX
OSTX
Os Therapies INCOS Therapies Incorporated has filed an S-1 registration statement to allow selling stockholders to resell up to 7.5 million shares, following positive Phase IIb clinical trial results for its lead Osteosarcoma drug candidate, OST-HER2, and the strategic acquisition of new immune-oncology assets.
AMEX
S-1/A: EON Resources Faces Going Concern Doubts Amidst Declining Production and Dilutive Capital Raises
EON Resources Inc. has filed an amended S-1 registration statement for the resale of up to 7,818,600 shares of Class A Common Stock by selling securityholders, while simultaneously addressing substantial doubt about its ability to continue as a going concern and reporting a net loss of $1.75 million for Q1 2025.
Nova LifeStyle, Inc. has filed an S-1 registration statement to raise up to $8 million through a common stock and warrant offering, while simultaneously addressing a Nasdaq minimum bid price deficiency that could lead to delisting.
AMEX
Picard Medical, Inc., a medical technology company specializing in total artificial hearts, has filed an amended S-1 registration statement for its initial public offering, revealing continued significant operating losses, a substantial working capital deficit, and an auditor's going concern warning, despite ongoing product development and international expansion efforts.
NASDAQ
ISPC
Ispecimen INCiSpecimen Inc. is launching an underwritten public offering of up to $4 million in common stock and pre-funded warrants to fund marketing and technology development, as its auditor raises substantial doubt about the company's ability to continue as a going concern.
OID
Farmers and Merchants Bancshares, Inc. has filed an S-1 registration statement for its 2025 Dividend Reinvestment Plan, allowing eligible stockholders to reinvest cash dividends in up to 500,000 new common shares, typically at a 5% discount, while also disclosing an inadvertent unregistered sale of shares from a prior plan.
NASDAQ
Elite Express Holding Inc., a California-based last-mile delivery service provider, has filed an S-1/A registration statement for an initial public offering of 4,000,000 Class A common shares at an estimated price of $4.00 per share, aiming to raise approximately $14 million in net proceeds to fund strategic acquisitions, fleet upgrades, and technology development.
OTC.Pink
EvoAir Holdings Inc., an eco-friendly HVAC and air purifying technology company, has filed an S-1/A registration statement for an initial public offering on the Nasdaq Capital Market, seeking to raise up to $17.25 million despite reporting significant and increasing net losses and a going concern warning.